Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 73SX2 | — |
patient was given Infanrix instead of Tdap; given to an 11 year old; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa (Infanrix) (batch number 73SX2, expiry date 24-MAR-2026) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis. On 03-MAR-2025, the patient received Infanrix. On an unknown date, the patient did not receive Tdap Vaccine. On 03-MAR-2025, an unknown time after receiving Infanrix and not applicable after receiving Tdap Vaccine, the patient experienced wrong vaccine administered (Verbatim: patient was given Infanrix instead of Tdap) and inappropriate age at vaccine administration (Verbatim: given to an 11 year old). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-MAR-2025 The staff member stated a patient was given Infanrix instead of Tdap which led to, wrong vaccine administered and inappropriate age at vaccine administration.